Objective: To investigate the clinical implications of obsessive-compulsive disorder (OCD) and ADHD comorbidity in adults. Method: The OCD patients who had and had no diagnosis of adulthood ADHD were compared in terms of several demographic and clinical variables. Results: The mean number of obsessions and compulsions; hoarding, symmetry, and miscellaneous obsessions; ordering/arranging and hoarding compulsions; total, attentional, and motor subscale scores of Barratt Impulsivity Scale (BIS)-11 were more frequent among the patients with OCD-ADHD. The mean age of onset was more likely to be earlier in ADHD-OCD group than in OCD group. Impulsivity, symmetry obsessions, and hoarding compulsions strongly predicted the coexistence between ADHD and OCD. Conclusion: OCD-ADHD comorbidity in adults seemed to be associated with an earlier onset of OCD, with the predominance of impulsivity, and with a different obsessive-compulsive symptom (OC) profile from OCD patients without a diagnosis of ADHD.
The association of lifetime suicidal behaviors with anxiety disorders (ADs) in patients with bipolar disorder (BD) has been controversial. In this study, we hypothesized that certain types of ADs were related to the occurrence of past suicide attempts (SAs) independent of the severity of the BD, including the presence of past affective episodes. Lifetime diagnoses of BD and ADs were assessed using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders (SCID-I). Of the total sample of 200 patients with BD, 32.0% had at least 1 past SA. The mean number of previous hospitalizations, a history of social AD, and a history of posttraumatic stress disorder were strongly associated with past SAs in patients with bipolar I disorder. The presence of lifetime social AD was associated with lifetime SAs independent of previous depressive episodes. Therefore, we suggest that social AD itself is associated with a greater risk for SAs in patients with BD independent of the presence of depression.
AIM: In the present study, we aimed to determine the volume differences in brain regions involved in cortical-striatal-thalamic-cortical circuit (CSTC) between healthy subjects and obsessive-compulsive disorder (OCD) patients. We also evaluated the potential relationship between volumes of region of interest and various illness parameters (duration and current severity OCD, and the influence of drug treatment). METHODS: We examined the volumetric differences in dorsolateral prefrontal cortex (DPFC), orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), thalamus and striatum between OCD patients (n = 21) and healthy controls (HCs) (n = 25). RESULTS: Patients with OCD had significantly larger total, right, and left DLPFC, and OFC volumes compared to HCs. Total, and left ACC, total, and left striatum volumes were significantly smaller in OCD patients than in HC. The thalamus volumes were not different between two groups. The most of volumetric correlations in HCs disappeared among OCD patients. Only, the correlation between the volumes of left striaum and left ACC volume remained significant. Fisher's r-to-z transformation tests indicated that correlation coefficients of brain volumes significantly differed between both groups for right ACC and left (z = 2.17, p = .03) and right OFC (z = 2.00, p = .04); left ACC and right OFC (z = 2.41, p = .01); right ACC and left (z = 2.94, p = .003), and right striatum (z = 2.43, p = .01). CONCLUSIONS: Our findings indicate the impaired connectivity of ACC, OFC, and striatum in the pathophysiology of OCD. Further research is needed to explore precisely which brain regions nuclei are specifically involved in the occurence of OCD symptoms.
ARTICLE HISTORY
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.